Acknowledgments: During the preparation of this manuscript/study, the author(s) used OpenAI GPT-4 and Perplexity AI GPT-4 for the purposes of extracting relevant quotations from full text articles, analyzing risk of bias for studies, generating a summary table, and generating a graphical abstract
Mayo KE, Miller LJ, Bataille D, Dalle S, Gke B, Thorens B, Drucker DJ: International Union of Pharmacology
We were able to single out a protein, Med14, whose activation downstream of GLP-1 helps reprogram pancreatic beta cell gene expression to improve the cells viability and insulin production. Often simply called GLP-1 drugs or GLPs, glucagon-like peptide-1 receptor agonists work by mimicking a hormone our bodies naturally make
Semaglutide Clinical Trials and Outcomes Supporting Expanded Testing Needs Semaglutides expanding clinical portfolio has generated one of the most extensive testing frameworks for any individual drug molecule: SUSTAIN program (Ozempic, T2D): Phases 1-10 clinical trials establishing once-weekly injectable semaglutides glycemic efficacy
Chemical Sensitivities and Toxin Intolerance: When Phase II liver detoxification pathways stall due to glutathione depletion, patients often become highly sensitive to medications, fragrances, and environmental chemicals